Cargando…
Severe COVID-19 infection associated with endothelial activation
Autores principales: | Escher, Robert, Breakey, Neal, Lämmle, Bernhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156948/ https://www.ncbi.nlm.nih.gov/pubmed/32305740 http://dx.doi.org/10.1016/j.thromres.2020.04.014 |
Ejemplares similares
-
ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
por: Escher, R., et al.
Publicado: (2020) -
Thrombophilia and outcomes of venous thromboembolism in older patients
por: Méan, Marie, et al.
Publicado: (2022) -
Endothelial Dysfunction, Atherosclerosis, and Increase of Von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine
por: Lämmle, Bernhard
Publicado: (2021) -
Endothelial cell infection and dysfunction, immune activation in severe COVID-19
por: Qin, Zhongnan, et al.
Publicado: (2021) -
Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research
por: Lämmle, Bernhard, et al.
Publicado: (2021)